Genetically-engineered company, Camgenium, creates an application designed to assist prostate cancer sufferers
The HealthiumPro app and software, developed by Camgenium in collaboration with Professor Petre Cristian Ilie and the NNUH NHS Foundation Trust, is making waves in the medical community. This cloud-based solution aims to improve outcomes for prostate cancer patients before and after surgery, addressing psychosocial, psychosexual, and informational needs through a patient-centric interface.
Built on the flexible Xenplate platform, HealthiumPro has been constructed in compliance with ISO 13485, the regulatory standard for medical devices. The system uses drag-and-drop design methods, minimizing the need for bespoke coding, and boasts pre-built regulatory compliant modules.
Currently, the app offers a range of features to support patients. These include allowing patients to sign consent forms and access pre-surgery information remotely, providing recommended pre-surgical physical exercises, enabling patients to view upcoming appointment details, facilitating remote monitoring of vital signs by clinicians, and automating surgical note documentation integrating patient-reported outcomes.
With prostate cancer being the most commonly diagnosed cancer in UK men, and the incidence rate expected to rise by 15% between 2023 and 2040, there is a significant need for digital solutions like HealthiumPro to improve clinical and psychosocial outcomes.
Looking ahead, future projections highlight continued development and wider adoption of HealthiumPro across NHS trusts. Plans include enhancing remote patient monitoring and engagement to support recovery and reduce hospital visits, integrating psychosexual support tools, and expanding data analytics to fine-tune personalized treatment pathways.
Dr. Philip Gaffney, CEO of Camgenium, has stated that the HealthiumPro system has improved patient care in hospitals where it has been deployed. The system's readiness for nationwide implementation in other healthcare settings bodes well for the future of prostate cancer care in the UK.
References:
[1] Camgenium. (n.d.). HealthiumPro. Retrieved from https://www.camgenium.com/healthiumpro
[2] NHS Digital. (2020). Prostate cancer. Retrieved from https://digital.nhs.uk/data-and-information/publications/statistical/prostate-cancer-statistics/prostate-cancer-statistics-2020
[3] Cancer Research UK. (2021). Prostate cancer statistics. Retrieved from https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer
Title: Streamlining Stent Management with HealthiumPro
In addition to its focus on prostate cancer patients, HealthiumPro includes a centralized stent database to streamline the logging and tracking of stent insertions to ensure timely removal or exchange. With no national electronic stent register currently used across the NHS, some hospitals still rely on paper-based logging with human oversight.
Leaving stents in for too long can lead to infection or the need for major surgery with potentially catastrophic outcomes for high-risk patients. By automating this process, HealthiumPro aims to reduce these risks and improve patient safety.
Camgenium's data centre hosts the HealthiumPro system, with the company working closely with the hospital's compliance team to ensure secure and compliant data handling. The system assists in the automation of writing surgical notes, allowing clinicians to add variables that change from patient to patient and correlate surgical data with patient-reported outcomes.
Title: The Future of HealthiumPro: Expanding Support and Personalized Care
As HealthiumPro continues to evolve, its focus on expanding support and personalized care for prostate cancer patients remains at the forefront. Future plans include enhancing remote patient monitoring and engagement to support recovery and reduce hospital visits, integrating psychosexual support tools, and expanding data analytics to fine-tune personalized treatment pathways.
These developments aim to holistically address the unmet psychosocial, psychosexual, and informational needs of prostate cancer patients, particularly those undergoing surgical intervention. With regulatory approval to host the HealthiumPro system on the NHS private network, HSCN, and readiness for nationwide implementation in other healthcare settings, the future of prostate cancer care in the UK looks promising.
